{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:24:05Z","timestamp":1770978245882,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.drugalcdep.2017.08.019","type":"journal-article","created":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T17:02:43Z","timestamp":1504976563000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use"],"prefix":"10.1016","volume":"180","author":[{"given":"Andrew S.","family":"Huhn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Andrew","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jsat.2013.04.002","article-title":"Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification","volume":"45","author":"Bailey","year":"2013","journal-title":"J. Subst. Abuse Treat"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2007.11.018","article-title":"Opioid use disorder in the United States: insurance status and treatment access","volume":"94","author":"Becker","year":"2008","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0015","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1080\/10826084.2016.1200097","article-title":"Should the United States government repeal restrictions on buprenorphine\/naloxone treatment? Subst","volume":"51","author":"Blum","year":"2016","journal-title":"Use Misuse"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2105\/AJPH.2016.303591","article-title":"Suicide deaths with opioid poisoning in the United States: 1999\u20132014","volume":"107","author":"Braden","year":"2017","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0025","series-title":"2015 National Survey on Drug Use and Drug Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0030","series-title":"Health Insurance Coverage, Early Release of Estimates from the National Health Interview Survey, 2011","author":"Cohen","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"2015","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/00952990.2015.1059842","article-title":"Rural substance use treatment centers in the United States: an assessment of treatment quality by location","volume":"41","author":"Edmond","year":"2015","journal-title":"Am. J. Drug Alcohol. Abuse"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0050","first-page":"e55","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"J. Inf."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.addbeh.2016.08.027","article-title":"The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence\u2013an assessment of demographic and substance use trends, United States, 2003\u20132014","volume":"65","author":"Jones","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0060","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence A double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-010-0793-6","article-title":"The pharmacological treatment of opioid addiction\u2013A clinical perspective","volume":"66","author":"Lobmaier","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3758\/s13428-011-0124-6","article-title":"Conducting behavioral research on amazon\u2019s mechanical turk","volume":"44","author":"Mason","year":"2012","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2016.02.004","article-title":"Outcomes for physicians with opioid dependence treated without agonist pharmacotherapy in physician health programs","volume":"64","author":"Merlo","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0085","series-title":"Motivational Interviewing: Helping People Change","author":"Miller","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0090","series-title":"Centers for Disease Control, Preventi, . Health, United States 2013, with Special Feature on Prescription Drugs","author":"National Center for Health Statistics","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1017\/S1930297500002205","article-title":"Running experiments on amazon mechanical turk","volume":"5","author":"Paolacci","year":"2010","journal-title":"Judg. Decis. Making"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","article-title":"Why don\u2019t out-of-treatment individuals enter methadone treatment programmes?","volume":"21","author":"Peterson","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0105","series-title":"Integrating Buprenorphine into an Opioid Treatment Program: Tailoring Care for Patients with Opioid Use Disorders","first-page":"201500501","author":"Polydorou","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.7326\/0003-4819-125-9-199611010-00010","article-title":"Physician recommendations and patient autonomy: finding a balance between physician power and patient choice","volume":"125","author":"Quill","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archpsyc.1985.01790340050008","article-title":"Untreated opiate addicts: how do they differ from those seeking treatment?","volume":"42","author":"Rounsaville","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.drugalcdep.2014.09.009","article-title":"Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder","volume":"144","author":"Schuman-Olivier","year":"2014","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0125","first-page":"1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence","volume":"283","author":"Sees","year":"2000","journal-title":"Randomized Controlled Trial JAMA"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2013.4450","article-title":"Access to treatment for opioid dependence in rural America: challenges and future directions","volume":"71","author":"Sigmon","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1468-0009.12137","article-title":"Where is buprenorphine dispensed to treat opioid use disorders? The role of private offices, opioid treatment programs, and substance abuse treatment facilities in urban and rural counties","volume":"93","author":"Stein","year":"2015","journal-title":"Milbank Q."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsat.2015.07.002","article-title":"Preferences for aftercare among persons seeking short-term opioid detoxification","volume":"59","author":"Stein","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0145","first-page":"16050548","article-title":"Long-acting injectable naltrexone induction: a randomized trial of outpatient opioid detoxification with naltrexone versus buprenorphine","volume":"2016","author":"Sullivan","year":"2017","journal-title":"Am. J. Psychiatryappi. AJP"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0150","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/j.pain.0000000000000576","article-title":"Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes","volume":"157","author":"Tompkins","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0155","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0160","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/08897077.2016.1187240","article-title":"Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists","volume":"37","author":"Wakeman","year":"2016","journal-title":"Subst. Abuse."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0165","first-page":"1715","article-title":"Integrating primary medical care with addiction treatment","volume":"286","author":"Weisner","year":"2001","journal-title":"Randomized Controlled Trial JAMA"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0170","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.drugalcdep.2017.08.019_bib0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2008.07.012","article-title":"Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males","volume":"99","author":"Zijlstra","year":"2009","journal-title":"Drug Alcohol. Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T16:01:38Z","timestamp":1692979298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617304507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":36,"alternative-id":["S0376871617304507"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.08.019","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}